ZyVersa Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
ZyVersa Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2022 to Q2 2024.
  • ZyVersa Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 21.5 %, a 42.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 21.5 -15.8 -42.4% Jun 30, 2024
Q1 2024 22.3 -30.9 -58% Mar 31, 2024
Q4 2023 22.7 -51.1 -69.2% Dec 31, 2023
Q3 2023 31.6 -60.8 -65.8% Sep 30, 2023
Q2 2023 37.2 Jun 30, 2023
Q1 2023 53.2 Mar 31, 2023
Q4 2022 73.8 Dec 31, 2022
Q3 2022 92.4 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.